Real-world changes in US health system hospital-based services following treatment with a prescription digital therapeutic for opioid use disorder
{{output}}
Outcomes associated with buprenorphine therapy for the treatment of opioid use disorder (OUD) are suboptimal. reSET-O is an FDA-authorized prescription digital therapeutic (PDT) delivering neurobehavioral therapy via mobile devices to patients with OUD treated... ...
